Literature DB >> 7677835

Genetic testing for familial hypertrophic cardiomyopathy in newborn infants.

M P Ryan1, J French, S al-Mahdawi, P Nihoyannopoulos, J G Cleland, C M Oakley, P S Harper, A Clarke, J Davis, L Grigg.   

Abstract

Entities:  

Keywords:  Genetics and Reproduction

Mesh：

Substances：

Year:  1995        PMID： 7677835      PMCID： PMC2549225          DOI： 10.1136/bmj.310.6983.856

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.

Authors:  A P Maggioni; M G Franzosi; E Santoro; H White; F Van de Werf; G Tognoni
Journal:  N Engl J Med       Date:  1992-07-02       Impact factor: 91.245

2.  Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.

Authors:  W J McKenna; R C Franklin; P Nihoyannopoulos; K C Robinson; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1988-01       Impact factor: 24.094

3.  Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy.

Authors:  S al-Mahdawi; S Chamberlain; J Cleland; P Nihoyannopoulos; D Gilligan; J French; L Choudhury; R Williamson; C Oakley
Journal:  Br Heart J       Date:  1993-02

4.  Screening for hypertrophic cardiomyopathy.

Authors:  A L Clark; A J Coats
Journal:  BMJ       Date:  1993-02-13

5.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

6.  Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

Authors:  N D Epstein; G M Cohn; F Cyran; L Fananapazir
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

7.  Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.

Authors:  W Linz; B A Schölkens; D Ganten
Journal:  Clin Exp Hypertens A       Date:  1989

8.  Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes.

Authors:  A Rosenzweig; H Watkins; D S Hwang; M Miri; W McKenna; T A Traill; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1991-12-19       Impact factor: 91.245

9.  Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy.

Authors:  B J Maron; P Spirito; Y Wesley; J Arce
Journal:  N Engl J Med       Date:  1986-09-04       Impact factor: 91.245
  9 in total
  6 in total

1.  Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. A positive screening test for an untreatable condition provides psychological relief from uncertainty.

Authors:  T Marteau; S Michie
Journal:  BMJ       Date:  1995-07-01

2.  Left ventricular hypertrophy is prevalent in Sprague-Dawley rats.

Authors:  Ryan M McAdams; Ronald J McPherson; Nazila M Dabestani; Christine A Gleason; Sandra E Juul
Journal:  Comp Med       Date:  2010-10       Impact factor: 0.982

3.  Counselling issues in familial hypertrophic cardiomyopathy.

Authors:  B Yu; J A French; R W Jeremy; P French; D R McTaggart; M R Nicholson; C Semsarian; D R Richmond; R J Trent
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

4.  Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. Hypertrophic cardiomyopathy can be treated but not cured.

Authors:  J F Goodwin
Journal:  BMJ       Date:  1995-07-01

5.  Parental knowledge and attitudes toward hypertrophic cardiomyopathy genetic testing.

Authors:  Sara M Fitzgerald-Butt; Lindsey Byrne; Cynthia A Gerhardt; Kathryn Vannatta; Timothy M Hoffman; Kim L McBride
Journal:  Pediatr Cardiol       Date:  2009-12-01       Impact factor: 1.655

6.  Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience.

Authors:  M Michels; Y M Hoedemaekers; M J Kofflard; I Frohn-Mulder; D Dooijes; D Majoor-Krakauer; F J Ten Cate
Journal:  Neth Heart J       Date:  2007-05       Impact factor: 2.380
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.